Evaluation and follow-up strategies for superficial bladder cancer
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 30 (4) , 765-776
- https://doi.org/10.1016/s0094-0143(03)00060-0
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the BladderJournal of Clinical Oncology, 2002
- Follow‐up surveillance strategies for genitourinary malignanciesCancer, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- MECHANISMS OF PROSTATIC STROMAL INVASION IN PATIENTS WITH BLADDER CANCER: CLINICAL SIGNIFICANCEJournal of Urology, 2001
- THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 2001
- SECOND RESECTION AND PROGNOSIS OF PRIMARY HIGH RISK SUPERFICIAL BLADDER CANCER: IS CYSTECTOMY OFTEN TOO EARLY?Journal of Urology, 2001
- THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORSJournal of Urology, 1999
- Genetic studies and molecular markers of bladder cancerSeminars in Surgical Oncology, 1997
- Upper Tract Tumors in Patients with Primary Bladder Cancer Followed for 15 YearsJournal of Urology, 1996
- Reassessment of Conservative Management for Stage T1N0M0 Transitional Cell Carcinoma of the BladderJournal of Urology, 1996